The DMV cannabis landscape is evolving fast: D.C.: Tightening ads — limiting youth exposure, content rules Virginia: Building retail framework — July applications, Nov sales One jurisdiction refining. One building from scratch. Both navigating the same federal uncertainty. Progress looks different everywhere. But it’s all progress. Outlaw Report covers two significant developments in the DMV cannabis landscape. Washington D.C.
Cannabis Use Disorder Clinical Trial Pipeline Gains Momentum
The federal executive order on cannabis rescheduling does NOT make recreational marijuana legal—it eases research restrictions and tax burdens, but full legalization still requires an act of Congress. OpenPR reports that the clinical trial pipeline for cannabis use disorder (CUD) treatments is gaining momentum, with pharmaceutical R&D intensifying focus on targeted therapies. Aelis Farma is advancing AEF0117, a selective CB1 modulator, through Phase II trials.